Abstract
Clinicians are seeing a growing number of cashew nut allergic patients. One of the peculiarities of this allergy is that a minimal amount of cashew nut allergen may cause severe allergic reactions, suggesting high potency of the allergen comparable to other tree nuts and peanuts.The double blind placebo controlled food challenge (DBPCFC) test is currently the gold standard to establish cashew nut allergy. The development of predictive tools in diagnosing cashew nut allergy is needed and research should be done on cross-sensitization between cashew nut and other botanically related allergens.
| Original language | English |
|---|---|
| Article number | 183 |
| Journal | Allergy |
| Volume | 70 |
| Issue number | Suppl. 101 |
| Pages (from-to) | 90-90 |
| Number of pages | 1 |
| ISSN | 0105-4538 |
| DOIs | |
| Publication status | Published - 2015 |
| Event | European Academy of Allergy and Clinical Immunology Congress 2015 - Barcelona, Spain Duration: 6 Jun 2015 → 10 Jun 2015 https://eaaci.org/documents/congress/2021/150519%20BAJA%20Final_Programme_Barcelona_2015.pdf |
Conference
| Conference | European Academy of Allergy and Clinical Immunology Congress 2015 |
|---|---|
| Country/Territory | Spain |
| City | Barcelona |
| Period | 06/06/2015 → 10/06/2015 |
| Internet address |
Fingerprint
Dive into the research topics of 'Ultra-high density peptide arrays demonstrate unique patient-specific IgE and IgG4 epitope patterns for peanut allergens that persist over multiple years'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver